Literature DB >> 2027754

Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA.

M A Romanos1, A J Makoff, N F Fairweather, K M Beesley, D E Slater, F B Rayment, M M Payne, J J Clare.   

Abstract

Fragment C is a non-toxic 50 kDa fragment of tetanus toxin which is a candidate subunit vaccine against tetanus. The AT-rich Clostridium tetani DNA encoding fragment C could not be expressed in Saccharomyces cerevisiae due to the presence of several fortuitous polyadenylation sites which gave rise to truncated mRNAs. The polyadenylation sites were eliminated by chemically synthesising the DNA with increased GC-content (from 29% to 47%). Synthesis of the entire gene (1400 base pairs) was necessary to generate full-length transcripts and for protein production in yeast. Using a GAL1 promoter vector, fragment C was expressed to 2-3% of soluble cell protein. Fragment C could also be secreted using the alpha-factor leader peptide as a secretion signal. The protein was present at 5-10 mg/l in the culture medium in two forms: a high molecular mass hyper-glycosylated protein (75-200 kDa) and a core-glycosylated protein (65 kDa). Intracellular fragment C was as effective in vaccinating mice against tetanus authentic fragment C. The glycosylated material was inactive, though it was rendered fully active by de-glycosylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027754      PMCID: PMC333902          DOI: 10.1093/nar/19.7.1461

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

1.  Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties.

Authors:  K M Beesley; M J Francis; B E Clarke; J E Beesley; P J Dopping-Hepenstal; J J Clare; F Brown; M A Romanos
Journal:  Biotechnology (N Y)       Date:  1990-07

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.

Authors:  T B Helting; O Zwisler
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

4.  Sequences responsible for transcription termination on a gene segment in Saccharomyces cerevisiae.

Authors:  S Henikoff; E H Cohen
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

5.  Mutationally altered 3' ends of yeast CYC1 mRNA affect transcript stability and translational efficiency.

Authors:  K S Zaret; F Sherman
Journal:  J Mol Biol       Date:  1984-07-25       Impact factor: 5.469

6.  Analysis of the immune response to papain digestion products of tetanus toxin.

Authors:  T B Helting; H H Nau
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1984-02

7.  DNA sequence required for efficient transcription termination in yeast.

Authors:  K S Zaret; F Sherman
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

8.  Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae.

Authors:  M Johnston; R W Davis
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

9.  Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons.

Authors:  A J Makoff; M D Oxer; M A Romanos; N F Fairweather; S Ballantine
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

10.  Mutant defective in processing of an enzyme located in the lysosome-like vacuole of Saccharomyces cerevisiae.

Authors:  B A Hemmings; G S Zubenko; A Hasilik; E W Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  17 in total

1.  Bacterial spores as vaccine vehicles.

Authors:  Le H Duc; Huynh A Hong; Neil Fairweather; Ezio Ricca; Simon M Cutting
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  Expression of tetanus toxin Fragment C in tobacco chloroplasts.

Authors:  John S Tregoning; Peter Nixon; Hiroshi Kuroda; Zora Svab; Simon Clare; Frances Bowe; Neil Fairweather; Jimmy Ytterberg; Klaas J van Wijk; Gordon Dougan; Pal Maliga
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

3.  Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes.

Authors:  Ruth E Soria-Guerra; Sergio Rosales-Mendoza; Leticia Moreno-Fierros; Rubén López-Revilla; Angel G Alpuche-Solís
Journal:  Plant Cell Rep       Date:  2010-12-25       Impact factor: 4.570

4.  Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Authors:  R Zichel; A Mimran; A Keren; A Barnea; I Steinberger-Levy; D Marcus; A Turgeman; S Reuveny
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

5.  Characterization of recombinant tetanus toxin derivatives suitable for vaccine development.

Authors:  D Figueiredo; C Turcotte; G Frankel; Y Li; O Dolly; G Wilkin; D Marriott; N Fairweather; G Dougan
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

6.  Living colors in the gray mold pathogen Botrytis cinerea: codon-optimized genes encoding green fluorescent protein and mCherry, which exhibit bright fluorescence.

Authors:  Michaela Leroch; Dennis Mernke; Dieter Koppenhoefer; Prisca Schneider; Andreas Mosbach; Gunther Doehlemann; Matthias Hahn
Journal:  Appl Environ Microbiol       Date:  2011-03-04       Impact factor: 4.792

7.  Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.

Authors:  J S Lee; P Pushko; M D Parker; M T Dertzbaugh; L A Smith; J F Smith
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin.

Authors:  R Anderson; X M Gao; A Papakonstantinopoulou; M Roberts; G Dougan
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

9.  Glucoamylase gene fusions alleviate limitations for protein production in Aspergillus awamori at the transcriptional and (post) translational levels.

Authors:  R J Gouka; P J Punt; C A van den Hondel
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

10.  Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.

Authors:  Yun-Zhou Yu; Na Li; Rui-Lin Wang; Heng-Qi Zhu; Shuang Wang; Wei-Yuan Yu; Zhi-Wei Sun
Journal:  Clin Vaccine Immunol       Date:  2008-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.